GlaxoSmithKline PLC Director/PDMR Shareholding (8734N)
September 26 2019 - 1:26PM
UK Regulatory
TIDMGSK
RNS Number : 8734N
GlaxoSmithKline PLC
26 September 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA')
==== ===========================================================================================
a) Name Ms E Walmsley
==== ===================================== ====================================================
b) Position/status Chief Executive Officer
==== ===================================== ====================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== ====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== ====================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== ====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ===================================== ====================================================
b) Nature of the Following the vesting on 23 September 2019
transaction of 25% of an award made on 12 June 2014
under the GlaxoSmithKline Deferred Investment
Award Plan, Ms Walmsley will receive a
cash payment of GBP179,840.84 less applicable
tax withholding in respect of 10,667.982
notional Ordinary Shares.
==== ===================================== ====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ========================= ======================
GBP16.8580 10,667.982
==================================================================== ======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= =============================
e) Date of the transaction 2019-09-23
==== ===================================== ====================================================
f) Place of the N/A
transaction
==== ===================================== ====================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHDQLFLKKFLBBZ
(END) Dow Jones Newswires
September 26, 2019 13:26 ET (17:26 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024